Labs & testing

The feedback layer.

Tests don't make decisions — clinicians do. These cards show what each test can and cannot tell you.

Epigenomic testing — emerging
Epigenetic and biological-age tests should be treated as emerging tools unless tied to validated clinical decisions. Do not use them as stand-alone diagnostics or as proof that a protocol reverses disease.
  • Cardiometabolic

    ApoB

    A

    Atherogenic particle count.

    Sample:
    Serum
    Order when:
    Risk assessment, LDL/triglyceride discordance.
    Avoid when:
    Acute illness with distorted lipids.
    Tells you:
    Particle burden.
    Doesn't tell you:
    Plaque burden directly.
  • Cardiometabolic

    Lp(a)

    A

    Heritable cardiovascular risk modifier.

    Sample:
    Serum
    Order when:
    Once in adulthood; family CVD history.
    Avoid when:
    Routine repeat testing.
    Tells you:
    Inherited risk magnitude.
    Doesn't tell you:
    Whether disease is currently progressing.
  • Cardiometabolic

    HbA1c + fasting insulin

    A

    Glycemic control and insulin resistance signal.

    Sample:
    Serum
    Order when:
    Metabolic risk, weight changes, peptide therapy monitoring.
    Avoid when:
    Hemoglobinopathy without adjusted method.
    Tells you:
    Average glycemia + insulin context.
    Doesn't tell you:
    Acute glucose excursions (use CGM).
  • Inflammation

    hs-CRP

    A

    Low-grade systemic inflammation.

    Sample:
    Serum
    Order when:
    CV risk, chronic disease monitoring.
    Avoid when:
    Acute infection.
    Tells you:
    Inflammatory state at baseline.
    Doesn't tell you:
    Source of inflammation.
  • Cardiometabolic

    Ferritin + transferrin saturation

    A

    Iron stores; HFE workup.

    Sample:
    Serum
    Order when:
    Fatigue, family history of hemochromatosis, HFE variant.
    Avoid when:
    Acute inflammation alone (ferritin is acute-phase).
    Tells you:
    Iron overload or deficiency context.
    Doesn't tell you:
    Tissue iron without imaging.
  • Nutrigenomic

    Homocysteine

    B

    Functional B-vitamin/methylation marker.

    Sample:
    Serum
    Order when:
    When result will change a decision (e.g., MTHFR context).
    Avoid when:
    Routine 'methylation' panels without indication.
    Tells you:
    Functional B12/folate/renal/thyroid context.
    Doesn't tell you:
    MTHFR genotype directly.
    Multifactorial; do not over-attribute to MTHFR.
  • Microbiome

    Microbiome stool sequencing (commercial)

    C

    Compositional / functional snapshot.

    Sample:
    Stool
    Order when:
    Research-curious patients; symptom correlation in select cases.
    Avoid when:
    As a stand-alone diagnostic.
    Tells you:
    Relative abundance, diversity proxies.
    Doesn't tell you:
    Disease diagnosis; causality.
  • Genomic

    Targeted clinical gene panel

    A

    Test selected genes for a clinical question.

    Sample:
    Blood/saliva
    Order when:
    Defined phenotype or family history.
    Avoid when:
    Wellness curiosity without indication.
    Tells you:
    Pathogenic/likely-pathogenic variants in panel genes.
    Doesn't tell you:
    Variants outside panel; CNVs unless designed for them.
    Counseling: Recommended
  • Genomic

    Whole exome sequencing (WES)

    A

    Diagnostic in unexplained disease.

    Sample:
    Blood/saliva
    Order when:
    Rare disease workup, multisystem features.
    Avoid when:
    Population screening.
    Tells you:
    Coding variants across the exome.
    Doesn't tell you:
    Most non-coding, structural, repeat-expansion variants.
    Counseling: Required
  • Genomic

    Whole genome sequencing (WGS)

    A

    Broadest genomic interrogation.

    Sample:
    Blood/saliva
    Order when:
    Specialist context; some rare-disease pathways.
    Avoid when:
    Routine wellness.
    Tells you:
    Coding + much non-coding/structural variation.
    Doesn't tell you:
    All clinical meaning of every variant.
    Counseling: Required
  • Genomic

    Chromosomal microarray

    A

    Detect CNVs and large structural changes.

    Sample:
    Blood
    Order when:
    Developmental delay, congenital anomalies.
    Avoid when:
    SNV-only questions.
    Tells you:
    Copy-number changes.
    Doesn't tell you:
    Single-nucleotide variants.
    Counseling: Recommended
  • Genomic

    Mitochondrial DNA testing

    A

    Mitochondrial disease workup.

    Sample:
    Blood/tissue
    Order when:
    Suspected mitochondrial syndrome.
    Avoid when:
    Wellness screening.
    Tells you:
    mtDNA variants, heteroplasmy.
    Doesn't tell you:
    Nuclear-encoded mitochondrial disease alone.
    Counseling: Required
  • Genomic

    Reproductive carrier screening

    A

    Reproductive planning.

    Sample:
    Blood/saliva
    Order when:
    Pre-conception or early pregnancy.
    Avoid when:
    As a personal disease-risk test.
    Tells you:
    Carrier status for screened conditions.
    Doesn't tell you:
    Personal risk for most screened conditions.
    Counseling: Recommended
  • Genomic

    Tumor (somatic) sequencing

    A

    Therapy selection in oncology.

    Sample:
    Tumor tissue
    Order when:
    Per oncology pathway.
    Avoid when:
    Without oncology coordination.
    Tells you:
    Somatic variants guiding therapy.
    Doesn't tell you:
    Inherited risk (germline test required).
    Counseling: Recommended
  • Genomic

    Familial / cascade variant testing

    A

    Test relatives for a known family variant.

    Sample:
    Blood/saliva
    Order when:
    After a pathogenic finding in proband.
    Avoid when:
    Without a confirmed proband variant.
    Tells you:
    Carrier status for that variant.
    Doesn't tell you:
    Other inherited risks.
    Counseling: Recommended
  • Pharmacogenomic

    CYP2D6

    A

    Metabolism of many psychotropics, opioids.

    Sample:
    Blood/saliva
    Order when:
    Before/at suboptimal response or toxicity.
    Avoid when:
    Without a relevant prescribing decision.
    Tells you:
    Predicted phenotype.
    Doesn't tell you:
    All drug response variability.
  • Pharmacogenomic

    CYP2C19

    A

    Clopidogrel, PPIs, SSRIs.

    Sample:
    Blood/saliva
    Order when:
    Cardiology referral or SSRI/PPI decisions.
    Avoid when:
    Routine wellness.
    Tells you:
    Metabolizer phenotype.
    Doesn't tell you:
    All clinical outcomes.
  • Pharmacogenomic

    CYP2C9 + VKORC1

    B

    Warfarin dosing context.

    Sample:
    Blood/saliva
    Order when:
    Initiation of warfarin in selected cases.
    Avoid when:
    Routine.
    Tells you:
    Dosing context.
    Doesn't tell you:
    INR; still monitor.
  • Pharmacogenomic

    SLCO1B1

    B

    Statin-associated muscle symptom risk.

    Sample:
    Blood/saliva
    Order when:
    Considering high-dose simvastatin or recurrent SAMS.
    Avoid when:
    Routine.
    Tells you:
    Risk phenotype.
    Doesn't tell you:
    Whether SAMS will occur.
  • Pharmacogenomic

    TPMT / NUDT15

    A

    Thiopurine toxicity risk.

    Sample:
    Blood/saliva
    Order when:
    Before thiopurines.
    Avoid when:
    Without thiopurine plan.
    Tells you:
    Toxicity risk phenotype.
    Doesn't tell you:
    All adverse events.
  • Pharmacogenomic

    DPYD

    A

    Fluoropyrimidine toxicity risk.

    Sample:
    Blood/saliva
    Order when:
    Before 5-FU/capecitabine.
    Avoid when:
    Without plan for these agents.
    Tells you:
    Severe toxicity risk.
    Doesn't tell you:
    All toxicity.
  • Pharmacogenomic

    UGT1A1

    B

    Irinotecan and atazanavir context.

    Sample:
    Blood/saliva
    Order when:
    Per oncology/ID protocol.
    Avoid when:
    Routine.
    Tells you:
    Phenotype context.
    Doesn't tell you:
    All response.
  • Pharmacogenomic

    HLA-B*57:01

    A

    Abacavir hypersensitivity.

    Sample:
    Blood/saliva
    Order when:
    Before abacavir.
    Avoid when:
    Without that decision.
    Tells you:
    Risk allele presence.
    Doesn't tell you:
    Reaction certainty.
  • Pharmacogenomic

    HLA-B*15:02

    A

    Carbamazepine SJS risk in selected ancestries.

    Sample:
    Blood/saliva
    Order when:
    Before carbamazepine in higher-risk ancestry.
    Avoid when:
    Without that decision.
    Tells you:
    Risk allele.
    Doesn't tell you:
    All SJS risk.
  • Pharmacogenomic

    HLA-A*31:01

    B

    Carbamazepine cutaneous reactions.

    Sample:
    Blood/saliva
    Order when:
    Per guideline.
    Avoid when:
    Routine.
    Tells you:
    Risk allele.
    Doesn't tell you:
    All response.
  • Pharmacogenomic

    G6PD

    A

    Hemolysis risk with select drugs/foods.

    Sample:
    Blood
    Order when:
    Per guideline; family or ancestry context.
    Avoid when:
    Routine.
    Tells you:
    Activity level.
    Doesn't tell you:
    All hemolytic events.
  • Nutrigenomic

    HFE

    A

    Hereditary hemochromatosis context.

    Sample:
    Blood/saliva
    Order when:
    Iron studies abnormal; family history.
    Avoid when:
    Without iron-study context.
    Tells you:
    Common HFE variants.
    Doesn't tell you:
    All iron-overload causes.
  • Nutrigenomic

    LCT

    B

    Lactase persistence context.

    Sample:
    Blood/saliva
    Order when:
    When result changes plan.
    Avoid when:
    Routine.
    Tells you:
    Genotype context.
    Doesn't tell you:
    Symptoms or response.
  • Nutrigenomic

    ALDH2

    B

    Alcohol metabolism / risk counseling.

    Sample:
    Blood/saliva
    Order when:
    Relevant ancestry, alcohol-related decisions.
    Avoid when:
    Routine.
    Tells you:
    Metabolizer status.
    Doesn't tell you:
    All risk.
  • Nutrigenomic

    APOE

    B

    Cardiometabolic / neurodegenerative risk context.

    Sample:
    Blood/saliva
    Order when:
    With counseling; specific clinical questions.
    Avoid when:
    Without counseling.
    Tells you:
    Allele combination.
    Doesn't tell you:
    Whether disease will occur.
    Counseling: Required
  • Nutrigenomic

    MTHFR (C677T / A1298C)

    D

    Common polymorphism; over-claimed.

    Sample:
    Blood/saliva
    Order when:
    Rarely; pair with homocysteine and clinical context.
    Avoid when:
    Routine 'methylation' panels.
    Tells you:
    Genotype.
    Doesn't tell you:
    Whether you 'need methylated vitamins'.
    Do not over-prescribe based on SNP alone.
  • Nutrigenomic

    FADS1/FADS2

    C

    Fatty acid metabolism variants.

    Sample:
    Blood/saliva
    Order when:
    Research/select context.
    Avoid when:
    Routine.
    Tells you:
    Genotype.
    Doesn't tell you:
    Personal omega ratios.
  • Nutrigenomic

    FUT2 (secretor status)

    C

    Microbiome/B12 association context.

    Sample:
    Blood/saliva
    Order when:
    Research/curiosity with caveats.
    Avoid when:
    Routine clinical decision-making.
    Tells you:
    Secretor status.
    Doesn't tell you:
    Disease risk on its own.
  • Nutrigenomic

    TCF7L2 / FTO (polygenic context)

    C

    Diabetes/obesity polygenic context.

    Sample:
    Blood/saliva
    Order when:
    Polygenic risk research/selected cases.
    Avoid when:
    As single-SNP diagnosis.
    Tells you:
    Single-variant context.
    Doesn't tell you:
    Personal disease risk alone.
  • Nutrigenomic

    LPA genetic risk + Lp(a) lab

    A

    Heritable CV risk pairing.

    Sample:
    Blood
    Order when:
    Family CVD; precision lipid workup.
    Avoid when:
    Without lab context.
    Tells you:
    Inherited CV risk magnitude.
    Doesn't tell you:
    Acute events.
  • Epigenomic

    DNA methylation panel (commercial)

    D

    Research / education tool.

    Sample:
    Blood/saliva
    Order when:
    Education; rarely changes care.
    Avoid when:
    As stand-alone diagnostic or 'age reversal' proof.
    Tells you:
    Methylation summary statistics.
    Doesn't tell you:
    Clinical disease state.
  • Epigenomic

    Epigenetic age clock

    D

    Research-grade biological-age estimate.

    Sample:
    Blood/saliva
    Order when:
    Education only.
    Avoid when:
    As proof of clinical rejuvenation.
    Tells you:
    A model-derived age estimate.
    Doesn't tell you:
    Disease, mortality, or that any protocol works.